During the past decade, University of Zurich, Institute of Pharmacology and Toxicology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University of Zurich, Institute of Pharmacology and Toxicology" are "Healthy" (1 trials) and "Sleep" (1 trials). Many other conditions were trialed in "University of Zurich, Institute of Pharmacology and Toxicology" in a lesser frequency.

Most popular intervention types in "University of Zurich, Institute of Pharmacology and Toxicology" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "LTE field" (1 trials), "Placebo" (1 trials), "Tolcapone" (1 trials) and "sham field" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Zurich, Institute of Pharmacology and Toxicology" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Zurich, Institute of Pharmacology and Toxicology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in University of Zurich, Institute of Pharmacology and Toxicology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Zurich, Institute of Pharmacology and Toxicology, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".